Bruker Reports 21 Percent Rise in Revs
Bruker BioSciences this week said revenues rose 21.1 percent during its second quarter while profits jumped 95.6 percent.
For the three months ended June 30, the company posted receipts of $121.7 million, up from $100.5 million a year ago. Product revenues rose to $106.6 million, a 20.7 increase from $88.3 million a year ago.
The company did not break out financials for its separate divisions but in a conference call accompanying the release of its results, Frank Laukien, president and CEO of the company, said that its Daltonics division saw single-digit growth. Bruker Optics saw double-digit growth and Bruker AXS saw growth “well into the double-digits.”
Its proteomics business grew at about market rate, Laukien said.
Profits for the quarter rose to $4.9 million, up from $2.5 million during the year-ago period. The company spent $13.9 million on R&D during the quarter. As of June 30, Bruker had $41.9 million in cash and short-term investments.
PE Q2 Revs Rise 16 Percent, Profits Up Almost 38 Percent
PerkinElmer last week reported 17 percent growth in its Life and Analytical Sciences division revenues, resulting in a 16 percent rise in total receipts for the second quarter.
For the three months ended July 1, Life and Analytical Sciences sales climbed to $326.3 million, compared to $278.5 million a year ago. The division houses its proteomics operations. Total revenues reached $437.3 million from $377 million during the year-ago period.
Profits for the period were $33.7 million, a 37.6 percent spike from the year-ago profit of $24.5 million.
The company spent $27.3 million on R&D during the quarter, compared to $25 million a year ago. As of July 1, PerkinElmer had $150 million in cash and cash equivalents.
Its Optoelectronics division posted revenues of $111 million, a 13 percent increase from $98.5 million from a year ago.
For the third quarter, the company is projecting revenue growth in the low double digits.
USPTO to Grant Proteome Sciences Patent on Isobaric Mass Labeling Technology
Proteome Sciences said this week that the US Patent and Trademark Office issued a notice of allowance for the company’s patent application relating to isobaric mass labeling technology. The company has already been granted a patent on the technology in Europe, Australia, New Zealand, and Canada.
In a statement, Proteome Sciences said that once the patent is granted, other firms with products based on the technology will need to pay licensing fees “for the manufacture or use of any type of isobaric mass tags in their research programs.”
Applied Biosystems iTRAQ reagent and PerkinElmer’s ExacTag mass tags are based on isobaric mass tag technology.
Proteome Sciences also announced that the European Patent Office has issued a notice of intention to grant its patent application covering technology related to isobaric mass tags with peptide structures and various methods of their use.
Philips Licenses GeneGo’s MetaCore
GeneGo said this week that Philips Research has licensed its MetaCore technology. Terms of the deal were not disclosed and Philips did not say how it would be using the technology.